The tumor suppressor HINT1 regulates MITF and β-catenin transcriptional activity in melanoma cells

Cell Cycle

Volumn 11, Issue 11, 2012, Pages 2206-2215

  Genovese, Giannicola ^a,b,c   Ghosh, Papia ^c   Li, Haiyang ^a   Rettino, Alessando ^b   Sioletic, Stefano ^b   Cittadini, Achille ^b   Sgambato, Alessandro ^b  

^a NewYork Presbyterian Hospital   (United States)

^b CATHOLIC UNIVERSITY   (Italy)

^c HARVARD UNIVERSITY   (United States)

Author keywords

HIT protein superfamily; Melanoma; Tumor suppressor gene; Tumorigenesis

Indexed keywords

BETA CATENIN; CYCLIN D1; HISTONE DEACETYLASE 1; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; PROTEIN BCL 2; TRANSCRIPTION FACTOR SIN3A;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CHROMATIN; CONTROLLED STUDY; HISTIDINE TRIAD NUCLEOTIDE BINDING PROTEIN 1 GENE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN BINDING; TUMOR SUPPRESSOR GENE; UPREGULATION;

EID: 84861894470     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.20765     Document Type: Article

References (34)

1. Ghosh P, Chin L. Genetics and genomics of melanoma. Expert Rev Dermatol 2009; 4:131; PMID:20126509; http://dx.doi.org/10.1586/edm.09.2.
2. Du J, Widlund HR, Horstmann MA, Ramaswamy S, Ross K, Huber WE, et al. Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF. Cancer Cell 2004; 6:565-76; PMID:15607961; http://dx.doi.org/10.1016/j.ccr.2004.10.014.
3. Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 2005; 436:117-22; PMID:16001072; http://dx.doi.org/10.1038/nature03664.
4. Levy C, Khaled M, Fisher DE. MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol Med 2006; 12:406-14; PMID:16899407; http://dx.doi.org/10.1016/j.molmed.2006.07.008.
5. McGill GG, Haq R, Nishimura EK, Fisher DE. c-Met expression is regulated by Mitf in the melanocyte lineage. J Biol Chem 2006; 281:10365-73; PMID:16455654; http://dx.doi.org/10.1074/jbc.M513094200.
6. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P. Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science 1997; 275:1790- 2; PMID:9065403; http://dx.doi.org/10.1126/science.275.5307. 1790.
7. Li H, Zhang Y, Su T, Santella RM, Weinstein IB. Hint1 is a haplo-insufficient tumor suppressor in mice. Oncogene 2006; 25:713-21; PMID:16186798; http://dx.doi.org/10.1038/sj.onc.1209111.
8. Brenner C. Hint, Fhit and GalT: function, structure, evolution and mechanism of three branches of the histidine triad superfamily of nucleotide hydrolases and transferases. Biochemistry 2002; 41:9003- 14; PMID:12119013; http://dx.doi.org/10.1021/bi025942q.
9. Croce CM, Sozzi G, Huebner K. Role of FHIT in human cancer. J Clin Oncol 1999; 17:1618-24; PMID:10334551.
10. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996; 84:587-97; PMID:8598045; http://dx.doi.org/10.1016/S0092-8674(00) 81034-X.
11. Sozzi G, Veronese ML, Negrini M, Baffa R, Cotticelli MG, Inoue H, et al. The FHIT gene 3p14.2 is abnormal in lung cancer. Cell 1996; 85:17-26; PMID:8620533; http://dx.doi.org/10.1016/S0092-8674(00)81078-8.
12. Su T, Suzui M, Wang L, Lin CS, Xing WQ, Weinstein IB. Deletion of histidine triad nucleotide-binding protein 1/PKC-interacting protein in mice enhances cell growth and carcinogenesis. Proc Natl Acad Sci USA 2003; 100:7824-9; PMID:12810953; http://dx.doi.org/10.1073/pnas.1332160100.
13. Hua D, Hu Y, Wu YY, Cheng ZH, Yu J, Du X, et al. Quantitative methylation analysis of multiple genes using methylation-sensitive restriction enzyme-based quantitative PCR for the detection of hepato-cellular carcinoma. Exp Mol Pathol 2011; 91:455- 60; PMID:21600201; http://dx.doi.org/10.1016/j.yexmp.2011.05.001.
14. Huang H, Wei X, Su X, Qiao F, Xu Z, Gu D, et al. Clinical significance of expression of Hint1 and potential epigenetic mechanism in gastric cancer. Int J Oncol 2011; 38:1557-64; PMID:21468541.
15. Yuan BZ, Jefferson AM, Popescu NC, Reynolds SH. Aberrant gene expression in human non small cell lung carcinoma cells exposed to demethylating agent 5-aza-2'-deoxycytidine. Neoplasia 2004; 6:412- 9; PMID:15256063; http://dx.doi.org/10.1593/neo.03490.
16. Zhang YJ, Li H, Wu HC, Shen J, Wang L, Yu MW, et al. Silencing of Hint1, a novel tumor suppressor gene, by promoter hypermethylation in hepatocellular carcinoma. Cancer Lett 2009; 275:277-84; PMID:19081673; http://dx.doi.org/10. 1016/j.canlet.2008.10.042.
17. Weiske J, Huber O. The histidine triad protein Hint1 interacts with Pontin and Reptin and inhibits TCFbeta-catenin-mediated transcription. J Cell Sci 2005; 118:3117-29; PMID:16014379; http://dx.doi.org/10.1242/jcs.02437.
18. Wang L, Zhang Y, Li H, Xu Z, Santella RM, Weinstein IB. Hint1 inhibits growth and activator protein-1 activity in human colon cancer cells. Cancer Res 2007; 67:4700-8; PMID:17510397; http://dx.doi.org/10.1158/0008-5472.CAN-06-4645.
19. Radtke F, Clevers H. Self-renewal and cancer of the gut: two sides of a coin. Science 2005; 307:1904- 9; PMID:15790842; http://dx.doi.org/10.1126/ science.1104815.
20. Wang L, Li H, Zhang Y, Santella RM, Weinstein IB. HINT1 inhibits beta-catenin/TCF4, USF2 and NFkappaB activity in human hepatoma cells. Int J Cancer 2009; 124:1526-34; PMID:19089909; http://dx.doi.org/10.1002/ijc.24072.
21. Razin E, Zhang ZC, Nechushtan H, Frenkel S, Lee YN, Arudchandran R, et al. Suppression of microphthalmia transcriptional activity by its association with protein kinase C-interacting protein 1 in mast cells. J Biol Chem 1999; 274:34272-6; PMID:10567402; http://dx.doi.org/10.1074/jbc.274.48.34272.
22. Weinstein IB, Li H. Mast cells provide a "HINT"to the function of an exotic nucleotide. Immunity 2004; 20:119-20; PMID:14975234; http://dx.doi.org/10.1016/S1074-7613(04)00029-9.
23. Lee YN, Nechushtan H, Figov N, Razin E. The function of lysyl-tRNA synthetase and Ap4A as signaling regulators of MITF activity in FcepsilonRIactivated mast cells. Immunity 2004; 20:145-51; PMID:14975237; http://dx.doi.org/10.1016/S1074-7613(04)00020-2.
24. Dannenberg JH, David G, Zhong S, van der Torre J, Wong WH, Depinho RA. mSin3A corepressor regulates diverse transcriptional networks governing normal and neoplastic growth and survival. Genes Dev 2005; 19:1581-95; PMID:15998811; http://dx.doi.org/10.1101/gad.1286905.
25. Hassig CA, Tong JK, Fleischer TC, Owa T, Grable PG, Ayer DE, et al. A role for histone deacetylase activity in HDAC1-mediated transcriptional repression. Proc Natl Acad Sci USA 1998; 95:3519-24; PMID:9520398; http://dx.doi.org/10.1073/pnas.95.7.3519.
26. Talantov D, Mazumder A, Yu JX, Briggs T, Jiang Y, Backus J, et al. Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin Cancer Res 2005; 11:7234-42; PMID:16243793; http://dx.doi.org/10.1158/1078- 0432.CCR-05-0683.
27. Weiske J, Huber O. The histidine triad protein Hint1 triggers apoptosis independent of its enzymatic activity. J Biol Chem 2006; 281:27356-66; PMID:16835243; http://dx.doi.org/10.1074/jbc.M513452200.
28. Chawla R, Procknow JA, Tantravahi RV, Khurana JS, Litvin J, Reddy EP. Cooperativity of Cdk4R24C and Ras in melanoma development. Cell Cycle 2010; 9:3305-14; PMID:20703083; http://dx.doi. org/10.4161/cc.9.16.12632.
29. Villares GJ, Zigler M, Bar-Eli M. The emerging role of the thrombin receptor (PAR-1) in melanoma metastasis-a possible therapeutic target. Oncotarget 2011; 2:8-17; PMID:21378407.
30. Sgambato A, De Paola B, Migaldi M, Di Salvatore M, Rettino A, Rossi G, et al. Dystroglycan expression is reduced during prostate tumorigenesis and is regulated by androgens in prostate cancer cells. J Cell Physiol 2007; 213:528-39; PMID:17516554; http://dx.doi.org/10.1002/jcp.21130.
31. Rettino A, Rafanelli F, Genovese G, Goracci M, Cifarelli RA, Cittadini A, et al. Identification of Sp1 and GC-boxes as transcriptional regulators of mouse Dag1 gene promoter. Am J Physiol Cell Physiol 2009; 297:1113-23; PMID:19657058; http://dx.doi.org/10.1152/ajpcell.00189.2009.
32. McGill GG, Horstmann M, Widlund HR, Du J, Motyckova G, Nishimura EK, et al. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 2002; 109:707-18; PMID:12086670; http://dx.doi.org/10.1016/S0092-8674(02)00762-6.
33. Lin M, Wei LJ, Sellers WR, Lieberfarb M, Wong WH, Li C. dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data. Bioinformatics 2004; 20:1233-40; PMID:14871870; http://dx.doi.org/10.1093/ bioinformatics/bth069.
34. Sgambato A, Camerini A, Genovese G, De Luca F, Viacava P, Migaldi M, et al. Loss of nuclear p27(kip1) and α-dystroglycan is a frequent event and is a strong predictor of poor outcome in renal cell carcinoma. Cancer Sci 2010; 101:2080-6; PMID:20626751; http://dx.doi.org/10.1111/j.1349-7006.2010.01644.x.